EA201992463A1 - DRUG DELIVERY SYSTEM - Google Patents

DRUG DELIVERY SYSTEM

Info

Publication number
EA201992463A1
EA201992463A1 EA201992463A EA201992463A EA201992463A1 EA 201992463 A1 EA201992463 A1 EA 201992463A1 EA 201992463 A EA201992463 A EA 201992463A EA 201992463 A EA201992463 A EA 201992463A EA 201992463 A1 EA201992463 A1 EA 201992463A1
Authority
EA
Eurasian Patent Office
Prior art keywords
drug delivery
delivery system
present
immediate
release
Prior art date
Application number
EA201992463A
Other languages
Russian (ru)
Inventor
Йоханнес Мартинус Мария Блумерс
Анко Корнелус Эйссенс
Хендерик Виллем Фрейлинк
Леонардус Герардус Йозеф Де Леде
Original Assignee
Эб Ип Хибритабс Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эб Ип Хибритабс Б.В. filed Critical Эб Ип Хибритабс Б.В.
Publication of EA201992463A1 publication Critical patent/EA201992463A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к регулируемой во времени, с немедленным высвобождением системе доставки лекарственного средства для перорального введения первого активного ингредиента нуждающемуся в этом пациенту. Настоящее изобретение дополнительно относится к устройству для доставки двойного лекарственного средства, включающему регулируемую во времени, с немедленным высвобождением систему доставки лекарственного средства согласно настоящему изобретению, дополнительно включающему вторую оболочку, включающую второй активный ингредиент.The present invention relates to a time-controlled, immediate-release, drug delivery system for oral administration of the first active ingredient to a patient in need thereof. The present invention further relates to a dual drug delivery device comprising a time-controlled, immediate-release, drug delivery system according to the present invention, further comprising a second shell comprising a second active ingredient.

EA201992463A 2011-10-03 2012-05-14 DRUG DELIVERY SYSTEM EA201992463A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11183732 2011-10-03

Publications (1)

Publication Number Publication Date
EA201992463A1 true EA201992463A1 (en) 2020-05-31

Family

ID=70847644

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992463A EA201992463A1 (en) 2011-10-03 2012-05-14 DRUG DELIVERY SYSTEM

Country Status (1)

Country Link
EA (1) EA201992463A1 (en)

Similar Documents

Publication Publication Date Title
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
EA201391689A1 (en) SYSTEM OF DELIVERY MEDICINE
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
EA201491285A1 (en) IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID
CY1119798T1 (en) FORM IV IV Hydrochloride Ibabradine
TR201908596T4 (en) Spiro-lactam NMDA receptor modulators and their uses.
IN2014DN10548A (en)
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
PH12014501408A1 (en) Immediate release multi unit pellet system
AU2012347200A8 (en) Tablet capable of combatting misuse by injection
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
DK2651410T3 (en) Transdermal therapeutic system for administering an active substance
MX344846B (en) Combination of active loaded granules with additional actives.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
CY1115556T1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES DAVIGATRAN
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
PH12015500823A1 (en) Modified release formulations for oprozomib
MX340188B (en) Manufacturing of active-free granules and tablets comprising the same.
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
CR20140358A (en) DRUG ADMINISTRATION SYSTEM
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
MX2015005762A (en) Co-micronisation product comprising ulipristal acetate.
EA201490862A1 (en) OSMOTICALLY ACTIVE VAGINAL DELIVERY SYSTEM
MX364652B (en) Pharmaceutical formulation comprising ciclesonide.
EA201992463A1 (en) DRUG DELIVERY SYSTEM